Nanobodies Market - Global Industry Insights, Trends, Outlook, and Analysis, 2018-2026
Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research.
Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Nanobodies</strong> <strong>Market</strong> -<br />
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,<br />
AND OPPORTUNITY ANALYSIS, <strong>2018</strong>-<strong>2026</strong><br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Nanobodies</strong> <strong>Market</strong> – Overview<br />
<strong>Nanobodies</strong> are considered to be one of the best technology in the fields of research, diagnostics <strong>and</strong> therapy especially<br />
in cancer research. These technology was developed from antigen binding fragments, originating from Camelid heavychain<br />
antibodies. These molecules do not have light chains, which is an essential part of antibody found in humans.<br />
Based on the above finding, nanobodies molecule containing single-domain only were developed, <strong>and</strong> these molecules<br />
contain functional <strong>and</strong> structural properties similar to heavy chain antibodies. These molecules have several advantages<br />
as compared to the conventional antibodies such as small-size, nano to picomolar affinities, <strong>and</strong> multiple route of<br />
administration. Ablynx, which is acquired by Sanofi S.A., is one of the leading company in this market.<br />
Currently, no products are available in the market, but there are multiple products in the pipeline including few in very<br />
late stage of clinical trials. For instance, marketing authorization application for Caplacizumab for the treatment of<br />
acquired thrombotic thrombocytopenic purpura (aTTP) has been submitted to European Medicine Agency (EMA) in<br />
February 2017. The product, Caplacizumab, is expected to be launched in Europe in <strong>2018</strong>. Moreover, the company,<br />
Ablynx, is expected to file for biologic license agreement to the U.S. Food <strong>and</strong> Drug Administration (FDA) in <strong>2018</strong>,<br />
<strong>and</strong> is expected to launch this product in U.S. in 2019. Both, Europe <strong>and</strong> U.S. are the key markets for any biologics<br />
including monoclonal antibodies <strong>and</strong> are expected to be the high revenue generating market for nanobodies.<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Nanobodies</strong> <strong>Market</strong> Taxonomy:<br />
By Product Type:<br />
●<br />
●<br />
●<br />
●<br />
●<br />
Mono-specific<br />
Monovalent<br />
Multivalent<br />
Bi-paratopic<br />
Multi-specific<br />
By Indication:<br />
●<br />
●<br />
●<br />
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)<br />
Respiratory Syncytial Virus (RSV) Infection<br />
Rheumatoid Arthritis<br />
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1680<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Nanobodies</strong> <strong>Market</strong>: Key Players<br />
●<br />
Ablynx (now part of Sanofi S. A.<br />
●<br />
●<br />
●<br />
●<br />
●<br />
Novo Nordisk A/S,<br />
Merck & Co., Inc.,<br />
Merck KGaA,<br />
AbbVie, Inc., <strong>and</strong><br />
C.H. Boehringer Sohn AG & Ko. KG.<br />
View this report @<br />
https://www.coherentmarketinsights.com/ongoing-insight/nanobodies-market-1680<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> <strong>Insights</strong> is a global market intelligence <strong>and</strong> consulting organization<br />
focused on assisting its plethora of clients achieve transformational growth by helping<br />
them make critical business decisions. We are headquartered in India, with an office at<br />
the global financial capital in the U.S. Our client base includes players from across all<br />
business verticals in over 150 countries worldwide. We are uniquely positioned to help<br />
businesses around the globe deliver practical <strong>and</strong> lasting results through various<br />
recommendations about operational improvements, technologies, emerging market<br />
trends <strong>and</strong> new working methods. We offer both customized <strong>and</strong> syndicated market<br />
research reports that help our clients create visionary growth plans to provide traction to<br />
their business. We meticulously study emerging trends across various industries at both<br />
the global <strong>and</strong> regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
SECTOR COVERAGE<br />
Healthcare<br />
CLINICAL DIAGNOSTIC<br />
HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality <strong>and</strong> Fine Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic Ingredients<br />
Polymers & Resins<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
<strong>Insights</strong> Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEARC<br />
H<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts <strong>and</strong> Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> <strong>Insights</strong> excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, <strong>and</strong><br />
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across<br />
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our<br />
clients achieve better outcomes with uniquely designed <strong>and</strong> highly customized solutions. Our coverage includes insights that help our clients ensure sustained<br />
growth in developed markets <strong>and</strong> also key inputs to help them tap into emerging markets <strong>and</strong> exploit the plethora of opportunities posed therein.<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> <strong>Insights</strong><br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
THANK YOU<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
Change language